Related Experiment Video
Updated: Aug 9, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Interleukin-4 production by Fc epsilon R+ cells
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Abstract:
Among non-B, non-T cells in the spleen and among unfractionated bone marrow cells, there is a population of cells that are capable of producing IL-4 in response to cross-linkage of FC epsilon RI or Fc gamma RII. Their IL-4-producing capacity is strikingly enhanced by treatment of the cells or of the animals donating such cells with interleukin-3 (IL-3). Fc epsilon R+ cells constitute 1-2% of splenic non-B, non-T cells and of bone marrow cells from normal donors but they contain all the capacity to produce IL-4 in response to cross-linkage of Fc epsilon RI or Fc gamma RII or to treatment with ionomycin. Fc epsilon R- cells fail to make such responses. Electron-microscopic analysis indicates that virtually all the granulated or vacuolated Fc epsilon R+ cells are of the basophil lineage. However, it has not yet been resolved whether these cells or immature mast cells, presumably in the Fc epsilon R+ granule/vacuole-negative cell population, are the principal producers of IL-4 in response to these stimuli.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
09:43Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells
Published on: March 8, 2024
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...